Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (ANGEN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (ANGEN) has a cash flow conversion efficiency ratio of -0.002x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (TL-3.02 Million ≈ $-67.59K USD) by net assets (TL1.68 Billion ≈ $37.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ANGEN defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Senstar Technologies Ltd
NASDAQ:SNT
|
0.009x |
|
TY Holdings Co Ltd
KO:363280
|
-0.031x |
|
Gozco Plantations Tbk
JK:GZCO
|
-0.089x |
|
Mink Therapeutics Inc
NASDAQ:INKT
|
0.070x |
|
Innox Corporation
KQ:088390
|
-0.009x |
|
DocGo Inc
NASDAQ:DCGO
|
-41882.840x |
|
FST Corp. Ordinary Shares
NASDAQ:KBSX
|
0.414x |
|
Grove Collaborative Holdings, Inc.
NYSE:GROV
|
-0.093x |
Annual Cash Flow Conversion Efficiency for Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (2018–2024)
The table below shows the annual cash flow conversion efficiency of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see Anatolia Tani ve Biyoteknoloji Urunleri (ANGEN) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | TL1.55 Billion ≈ $34.75 Million |
TL141.41 Million ≈ $3.17 Million |
0.091x | -62.37% |
| 2023-12-31 | TL1.75 Billion ≈ $39.23 Million |
TL424.36 Million ≈ $9.50 Million |
0.242x | -36.41% |
| 2022-12-31 | TL816.40 Million ≈ $18.29 Million |
TL311.02 Million ≈ $6.97 Million |
0.381x | -22.74% |
| 2021-12-31 | TL825.79 Million ≈ $18.50 Million |
TL407.20 Million ≈ $9.12 Million |
0.493x | -29.63% |
| 2020-12-31 | TL336.01 Million ≈ $7.53 Million |
TL235.47 Million ≈ $5.27 Million |
0.701x | +81.53% |
| 2019-12-31 | TL17.32 Million ≈ $387.97K |
TL6.69 Million ≈ $149.77K |
0.386x | +16.46% |
| 2018-12-31 | TL9.53 Million ≈ $213.55K |
TL3.16 Million ≈ $70.79K |
0.331x | -- |
About Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret
Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S., a biotechnology company, engages in the design, development, and manufacture of real-time PCR kits, nucleic acid extraction kits, and automated nucleic acid extraction instruments in Turkey. It offers microbiology, genetic disorder, panel, sequencing, and food testing kits; and manual spin column and magnetic bead nucleic acid ext… Read more